669 related articles for article (PubMed ID: 15464951)
1. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.
Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H
Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951
[TBL] [Abstract][Full Text] [Related]
2. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
3. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.
Oberg CT; Blanchard H; Leffler H; Nilsson UJ
Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029
[TBL] [Abstract][Full Text] [Related]
4. Efficient and expedient two-step pyranose-retaining fluorescein conjugation of complex reducing oligosaccharides: galectin oligosaccharide specificity studies in a fluorescence polarization assay.
Oberg CT; Carlsson S; Fillion E; Leffler H; Nilsson UJ
Bioconjug Chem; 2003; 14(6):1289-97. PubMed ID: 14624646
[TBL] [Abstract][Full Text] [Related]
5. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
6. Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins.
Cederfur C; Salomonsson E; Nilsson J; Halim A; Oberg CT; Larson G; Nilsson UJ; Leffler H
Glycobiology; 2008 May; 18(5):384-94. PubMed ID: 18263896
[TBL] [Abstract][Full Text] [Related]
7. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants.
Dam TK; Gabius HJ; André S; Kaltner H; Lensch M; Brewer CF
Biochemistry; 2005 Sep; 44(37):12564-71. PubMed ID: 16156668
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
[TBL] [Abstract][Full Text] [Related]
9. An integrated computational analysis of the structure, dynamics, and ligand binding interactions of the human galectin network.
Guardia CM; Gauto DF; Di Lella S; Rabinovich GA; Martí MA; Estrin DA
J Chem Inf Model; 2011 Aug; 51(8):1918-30. PubMed ID: 21702482
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic binding studies of galectin-1, -3 and -7.
Brewer CF
Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.
Nagae M; Nishi N; Nakamura-Tsuruta S; Hirabayashi J; Wakatsuki S; Kato R
J Mol Biol; 2008 Jan; 375(1):119-35. PubMed ID: 18005988
[TBL] [Abstract][Full Text] [Related]
12. Quaternary solution structures of galectins-1, -3, and -7.
Morris S; Ahmad N; André S; Kaltner H; Gabius HJ; Brenowitz M; Brewer F
Glycobiology; 2004 Mar; 14(3):293-300. PubMed ID: 14693909
[TBL] [Abstract][Full Text] [Related]
13. Binding studies of adhesion/growth-regulatory galectins with glycoconjugates monitored by surface plasmon resonance and NMR spectroscopy.
Muñoz FJ; Santos JI; Ardá A; André S; Gabius HJ; Sinisterra JV; Jiménez-Barbero J; Hernáiz MJ
Org Biomol Chem; 2010 Jun; 8(13):2986-92. PubMed ID: 20461267
[TBL] [Abstract][Full Text] [Related]
14. Monovalent interactions of galectin-1.
Salomonsson E; Larumbe A; Tejler J; Tullberg E; Rydberg H; Sundin A; Khabut A; Frejd T; Lobsanov YD; Rini JM; Nilsson UJ; Leffler H
Biochemistry; 2010 Nov; 49(44):9518-32. PubMed ID: 20873803
[TBL] [Abstract][Full Text] [Related]
15. Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation.
Wu AM; Singh T; Wu JH; Lensch M; André S; Gabius HJ
Glycobiology; 2006 Jun; 16(6):524-37. PubMed ID: 16540530
[TBL] [Abstract][Full Text] [Related]
16. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
17. Activity-structure correlations in divergent lectin evolution: fine specificity of chicken galectin CG-14 and computational analysis of flexible ligand docking for CG-14 and the closely related CG-16.
Wu AM; Singh T; Liu JH; Krzeminski M; Russwurm R; Siebert HC; Bonvin AM; André S; Gabius HJ
Glycobiology; 2007 Feb; 17(2):165-84. PubMed ID: 17060369
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of galectin inhibitors.
Sörme P; Kahl-Knutsson B; Wellmar U; Magnusson BG; Leffler H; Nilsson UJ
Methods Enzymol; 2003; 363():157-69. PubMed ID: 14579574
[No Abstract] [Full Text] [Related]
19. Taloside inhibitors of galectin-1 and galectin-3.
Collins PM; Oberg CT; Leffler H; Nilsson UJ; Blanchard H
Chem Biol Drug Des; 2012 Mar; 79(3):339-46. PubMed ID: 22136701
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the galectin-1 carbohydrate recognition domain in terms of solvent occupancy.
Di Lella S; Martí MA; Alvarez RM; Estrin DA; Ricci JC
J Phys Chem B; 2007 Jun; 111(25):7360-6. PubMed ID: 17523619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
